Weigao Jericom

About Weigao Jericom

Weihai Weigaojie Likang Biomaterials Co., Ltd., operating as Weigao Jericom, is a specialized entity within the broader Weihai Weigao Group, a prominent Chinese medical device conglomerate. Established on August 25, 2010, the company has positioned itself as a high-tech enterprise focused on the dental medical device sector in China. Its core mission revolves around the research, manufacturing, sales, and training related to dental solutions, with a strategic emphasis on developing high-value implantable medical devices.

The firm operates in the competitive dental implant market, serving dental professionals and institutions. Its business model integrates manufacturing with education, aiming to foster the adoption of advanced dental technologies across the country. Revenue is generated through the direct sale of its extensive product portfolio. In August 2023, the company secured significant A-round financing amounting to several hundred million RMB from investors including Zhouji Tongli Asset, Qingdao Chuangjing Fund, and CITIC Securities, signaling strong market confidence in its growth trajectory. This capital injection is intended to expand production capacity, accelerate pipeline development, and support research into new materials.

Weigao Jericom's flagship offering is the WEGO/JERICOM dental implant system, a product of independent research and development that holds national patents. The product line is comprehensive, encompassing not only the implant systems but also surgical tools, restorative components, bone graft materials, and digital dentistry solutions like personalized CAD/CAM crowns. The company also provides a full suite of services, including dedicated training for dental practitioners through its Weigao Planting Training Center, to ensure the effective and safe use of its products and to promote the advancement of dental implantation techniques within China.